Video Interview: Corbus Sees 2016 As Pivotal Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Corbus Pharmaceuticals CEO Yuval Cohen explains why the next 12 months will be pivotal for the rare inflammatory disease company.